Taking steroids with semaglutide: what you need to know

Step 1 — Understand which type of steroid you mean

The word "steroid" covers very different drug classes. Corticosteroids (prednisolone, dexamethasone, budesonide and their relatives) are anti-inflammatory medicines prescribed for conditions ranging from asthma to lupus. Anabolic-androgenic steroids are synthetic derivatives of testosterone, sometimes used medically for certain hormonal conditions but more often taken without a prescription to build muscle. If you want a fuller explanation of how steroids interact with semaglutide, that is covered in detail on a dedicated page, but the interaction is distinct for each class.

For corticosteroids, the core concern is blood glucose. These medicines signal the liver to release more glucose and reduce cells' sensitivity to insulin, which can send blood sugar markedly higher. Semaglutide works partly by modulating insulin and glucagon secretion in a glucose-dependent way, so a corticosteroid that pushes glucose up can blunt that effect or, in people with diabetes, cause glucose control to become unstable. Semaglutide's mechanism is covered in detail elsewhere on the site, but the short version is that it relies on a relatively stable metabolic environment to work predictably.

For anabolic steroids, the picture is less well characterised. They affect body composition, sex hormone levels and liver enzymes, all of which can influence weight and metabolism. There is no robust clinical evidence specifically examining the combination with semaglutide. That absence of evidence is itself a clinical signal: your prescriber cannot reassure you it is safe without assessing your full picture.

Step 2, Consider the specifics of your steroid use

Not all steroid exposure is the same. A five-day course of oral prednisolone for a chest infection is a very different situation from daily inhaled budesonide for asthma or long-term oral prednisolone for an autoimmune condition.

Inhaled and topical corticosteroids at standard therapeutic doses have minimal systemic absorption and are unlikely to cause meaningful blood glucose changes in most people. Joint injections (intra-articular corticosteroids) can cause a temporary local-to-systemic glucose spike, particularly in the 24–72 hours after injection, but the effect usually resolves. Oral or intravenous corticosteroids at moderate-to-high doses, or used for extended periods, carry the most significant interaction risk with semaglutide.

Route and duration matter enormously. If you are mid-course of a short oral steroid prescription and you take semaglutide, the main practical thing is to be alert to unusual symptoms, keep your prescriber informed, and not adjust your semaglutide dose yourself. The full list of medicines that require careful thought alongside semaglutide is broader than steroids alone and is worth reviewing.

The NHS patient guide on semaglutide advises telling your prescriber about all medicines, including over-the-counter products and supplements, before starting treatment.

Step 3, Tell your clinical team, then let them decide

The practical sequence here is straightforward. Before you start semaglutide, disclose every medicine you take, including any steroid, prescribed, over-the-counter or otherwise. If you are already on semaglutide and a doctor wants to start a corticosteroid, make sure they know you are on a GLP-1 medicine. That conversation costs nothing and prevents the kind of glucose instability that can sneak up quietly.

If you are managing a long-term condition that requires ongoing corticosteroid use, your prescriber may want to monitor blood glucose more frequently, particularly when starting semaglutide or increasing the dose. People with type 2 diabetes on corticosteroids sometimes need adjustments to their diabetes medicines, a detail covered in the BNF's semaglutide entry, which your prescriber uses as a professional reference.

The clinical picture can shift quickly. A GP who prescribes your prednisolone in the morning and knows about your semaglutide by lunchtime (before the school run, before the pharmacy dispenses it) is in a position to act. One who finds out weeks later is not. That gap is where problems develop.

If you are considering Wegovy for weight management and have a condition that requires regular steroid treatment, a clinical assessment is the right starting point. Our prescribers review the full picture, including concurrent medicines, before any treatment is approved. You can read more about Wegovy and how it works, or find out about the range of treatments we offer on our weight-loss treatment overview. For context on what treatment costs privately, the Wegovy pricing page sets out what is included in a single transparent price.

When to seek urgent medical advice

Most people combining corticosteroids and semaglutide under clinical supervision do so without serious incident. That said, certain symptoms should prompt same-day contact with a doctor or, if severe, a call to 111 or attendance at A&E.

Severe, persistent stomach pain that radiates to the back is associated with pancreatitis, a known but uncommon risk with GLP-1 medicines. The MHRA highlighted this in a January 2026 Drug Safety Update and asked patients and clinicians to take it seriously. Symptoms of very high blood glucose (unusual thirst, frequent urination, blurred vision, confusion) during or shortly after a corticosteroid course are also worth acting on promptly, do not wait to see if they settle. If you have any concern about a side effect or a possible interaction, you can report it directly at the MHRA Yellow Card scheme.

For personalised guidance on whether semaglutide is suitable for your situation, the best next step is a consultation with a qualified prescriber who can look at your full medicines list.